Rika Tanda

678 total citations
26 papers, 525 citations indexed

About

Rika Tanda is a scholar working on Public Health, Environmental and Occupational Health, Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Rika Tanda has authored 26 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 15 papers in Obstetrics and Gynecology and 10 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Rika Tanda's work include Reproductive Health and Contraception (15 papers), Maternal and Perinatal Health Interventions (12 papers) and Maternal and fetal healthcare (6 papers). Rika Tanda is often cited by papers focused on Reproductive Health and Contraception (15 papers), Maternal and Perinatal Health Interventions (12 papers) and Maternal and fetal healthcare (6 papers). Rika Tanda collaborates with scholars based in United States, Cuba and Spain. Rika Tanda's co-authors include Pamela J. Salsberry, A. Velazco, Carlos Sánchez, L. Varela, Patricia B. Reagan, J. L. L. Carbonell, Evelio Cabezas, Sharon A. Denham, F. Carrión Valero and Mitchell D. Creinin and has published in prestigious journals such as BMC Public Health, Journal of Developmental & Behavioral Pediatrics and Contraception.

In The Last Decade

Rika Tanda

25 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rika Tanda United States 14 410 292 287 44 32 26 525
Chris Dunkel Schetter United States 5 336 0.8× 186 0.6× 194 0.7× 38 0.9× 20 0.6× 6 507
Lem Ngongalah United Kingdom 8 216 0.5× 220 0.8× 245 0.9× 56 1.3× 50 1.6× 13 536
Songül Aktaş Türkiye 12 206 0.5× 100 0.3× 178 0.6× 41 0.9× 6 0.2× 38 390
P. Clarke United Kingdom 6 319 0.8× 73 0.3× 325 1.1× 30 0.7× 98 3.1× 11 452
Laurie Baksh United States 10 301 0.7× 184 0.6× 157 0.5× 86 2.0× 7 0.2× 16 437
Jessica Brumley United States 9 152 0.4× 188 0.6× 246 0.9× 72 1.6× 11 0.3× 12 459
Caragh Flannery Ireland 10 189 0.5× 66 0.2× 137 0.5× 85 1.9× 43 1.3× 22 374
Dılek Coşkuner Potur Türkiye 9 235 0.6× 87 0.3× 144 0.5× 55 1.3× 6 0.2× 30 359
Arianna I. Blaine United States 4 141 0.3× 483 1.7× 89 0.3× 60 1.4× 23 0.7× 5 622
Astrid Alvik Norway 10 147 0.4× 384 1.3× 216 0.8× 127 2.9× 10 0.3× 14 497

Countries citing papers authored by Rika Tanda

Since Specialization
Citations

This map shows the geographic impact of Rika Tanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rika Tanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rika Tanda more than expected).

Fields of papers citing papers by Rika Tanda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rika Tanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rika Tanda. The network helps show where Rika Tanda may publish in the future.

Co-authorship network of co-authors of Rika Tanda

This figure shows the co-authorship network connecting the top 25 collaborators of Rika Tanda. A scholar is included among the top collaborators of Rika Tanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rika Tanda. Rika Tanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tanda, Rika, et al.. (2020). Disparities in physical fitness of 6–11-year-old children: the 2012 NHANES National Youth Fitness Survey. BMC Public Health. 20(1). 1427–1427. 2 indexed citations
2.
Tanda, Rika, et al.. (2020). Changes in living arrangements of older persons in Egypt 2000-2014. 1(1). 60–72. 4 indexed citations
3.
Tanda, Rika, et al.. (2018). Factors That Modify the Association of Maternal Postpartum Smoking and Exclusive Breastfeeding Rates. Breastfeeding Medicine. 13(9). 614–621. 12 indexed citations
4.
Tanda, Rika, et al.. (2017). Factors associated with Ohio nurse practitioners’ childhood obesity preventive practice patterns. Journal of the American Association of Nurse Practitioners. 29(12). 763–772. 7 indexed citations
5.
Tanda, Rika & Pamela J. Salsberry. (2014). Racial Differences in the Association Between Maternal Prepregnancy Obesity and Children's Behavior Problems. Journal of Developmental & Behavioral Pediatrics. 35(2). 118–127. 18 indexed citations
6.
Tanda, Rika, et al.. (2012). The Impact of Prepregnancy Obesity on Children’s Cognitive Test Scores. Maternal and Child Health Journal. 17(2). 222–229. 92 indexed citations
7.
Coffey, Rebecca, et al.. (2011). Impact of the Implementation of an Alcohol Withdrawal Guideline on Patients With Burn Injuries. Clinical Nurse Specialist. 25(6). 286–293. 8 indexed citations
8.
Chipps, Esther, Celia E. Wills, Rika Tanda, et al.. (2011). Registered Nurses' Judgments of the Classification and Risk Level of Patient Care Errors. Journal of Nursing Care Quality. 26(4). 302–310. 9 indexed citations
9.
Tanda, Rika & Pamela J. Salsberry. (2011). Integrating Risks for Type 2 Diabetes Across Childhood: A Life Course Perspective. Journal of Pediatric Nursing. 27(4). 310–318. 5 indexed citations
10.
Carbonell, J. L. L., A. Velazco, Rika Tanda, et al.. (2003). Oral and vaginal misoprostol 800 μg every 8 h for early abortion. Contraception. 67(6). 457–462. 17 indexed citations
11.
Carbonell, J. L. L., et al.. (2001). Vaginal misoprostol 1000 μg for early abortion. Contraception. 63(3). 131–136. 27 indexed citations
12.
Carbonell, J. L. L., et al.. (2001). Oral versus vaginal misoprostol for cervical priming in first-trimester abortion: a randomized trial. The European Journal of Contraception & Reproductive Health Care. 6(3). 134–140. 1 indexed citations
13.
Velazco, A., L. Varela, Rika Tanda, et al.. (2000). Misoprostol for abortion up to 9 weeks' gestation in adolescents. The European Journal of Contraception & Reproductive Health Care. 5(4). 227–233. 20 indexed citations
14.
Carbonell, J. L. L., et al.. (2000). Vaginal misoprostol 600 μg for early abortion. The European Journal of Contraception & Reproductive Health Care. 5(1). 46–51. 10 indexed citations
15.
Creinin, Mitchell D., J. L. L. Carbonell, Jill L. Schwartz, L. Varela, & Rika Tanda. (1999). A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion. Contraception. 59(1). 11–16. 43 indexed citations
16.
Varela, L., et al.. (1999). Vaginal misoprostol for abortion at 10–13 weeks' gestation. The European Journal of Contraception & Reproductive Health Care. 4(1). 35–40. 20 indexed citations
17.
Varela, L., et al.. (1999). Early abortion with 800 μg of misoprostol by the vaginal route. Contraception. 59(4). 219–225. 54 indexed citations
18.
Varela, L., et al.. (1999). 25 mg or 50 mg of Oral Methotrexate Followed by Vaginal Misoprostol 7 Days after for Early Abortion. Gynecologic and Obstetric Investigation. 47(3). 182–187. 11 indexed citations
19.
Varela, L., et al.. (1998). Vaginal misoprostol for late first trimester abortion. Contraception. 57(5). 329–333. 40 indexed citations
20.
Velazco, A., et al.. (1998). Vaginal misoprostol for early second-trimester abortion. The European Journal of Contraception & Reproductive Health Care. 3(2). 93–98. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026